Imaging of Neuroendocrine Prostatic Carcinoma
Neuroendocrine prostate cancer (NEPC) is an aggressive subtype of prostate cancer that typically has a high metastatic potential and poor prognosis in comparison to the adenocarcinoma subtype. Although it can arise de novo, NEPC much more commonly occurs as a mechanism of treatment resistance during...
Guardado en:
Autores principales: | Ahmed Taher, Corey T. Jensen, Sireesha Yedururi, Devaki Shilpa Surasi, Silvana C. Faria, Tharakeshwar K. Bathala, Bilal Mujtaba, Priya Bhosale, Nicolaus Wagner-Bartak, Ajaykumar C. Morani |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/dd1261b0900845e2855ab4961515fcea |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Fatty Acid Metabolism Reprogramming in Advanced Prostate Cancer
por: Huan Xu, et al.
Publicado: (2021) -
Prevalencia del cáncer de próstata en la comuna de Talca, VII región Chile
por: Baechler R,Roberto, et al.
Publicado: (2001) -
Primary hepatic neuroendocrine carcinoma diagnosed by needle biopsy: a case report
por: Yusuke Seki, et al.
Publicado: (2021) -
Prostate cancer and prostatic diseases
Publicado: (1997) -
Small cell neuroendocrine carcinoma expressing alpha fetoprotein in the endometrium
por: Hou Weiwei, et al.
Publicado: (2021)